ICICI Prudential Nifty Pharma Index Fund

ICICI Prudential Mutual Fund · Index Funds (Equity) · Direct Idcw · AMFI 150928 · ISIN INF109KC12M7
NAV₹21.972820 Nov 2026
3Y return—a year
5Y return—a year
Expense ratio0.51%₹177 Cr
Growth Score—

Returns

1M3M6MYTD1Y3Y5Y7Y10YSince launch
Fund——————————
NIFTY Pharma TRI+10.85%+7.49%+14.67%+25.66%+25.86%+22.31%+16.87%———
Category middle+8.41%+0.48%+6.20%+2.07%+1.17%+11.34%+8.84%+12.47%+13.25%—

Risk (36 months)

Volatility—
Sharpe—
Sortino—
Beta—
Alpha—
Deepest fall—
1-year periods with a loss—
5Y SIP XIRR—

Top holdings (31 Oct 2026)

Sun Pharmaceutical Industries Ltd.18.60%
Divi's Laboratories Ltd.12.28%
Laurus Labs Ltd.9.26%
Dr. Reddy's Laboratories Ltd.8.15%
Cipla Ltd.7.67%
Torrent Pharmaceuticals Ltd.6.71%
Lupin Ltd.4.83%
Aurobindo Pharma Ltd.4.59%
Glenmark Pharmaceuticals Ltd.3.42%
Zydus Lifesciences Ltd.3.05%
Alkem Laboratories Ltd.3.04%
Mankind Pharma Ltd.2.79%

Sectors

Pharmaceuticals & Biotechnology99.9%

Calculated by Growth Analyser from AMFI NAVs and the fund house's disclosed portfolio. Up to 1 year: total return; longer: CAGR. Research and education only; not investment advice. Mutual fund investments are subject to market risks; read all scheme-related documents carefully. Past performance does not indicate future returns.